Subscription Rights for 2027

Summary by AI BETAClose X

Geiger Counter Limited has announced that shareholders are entitled to subscribe for one new Ordinary Share for every five Ordinary Shares held as of 30 April annually. The Subscription Rights Price was set at 94.26 pence on 5 May 2026, with the next exercise date anticipated for 30 April 2027. New Ordinary Shares will be issued to registered shareholders within 14 business days of the subscription date.

Disclaimer*

Geiger Counter Ltd
06 May 2026
 

Geiger Counter Limited (or the "Company")

6 May 2026

Notification to Shareholders in regard to Subscription Rights

 

The Board of the Company announces that shareholders currently have the right to subscribe for one new Ordinary Share for every five Ordinary Shares held in the Company on 30 April each year.

The Company announces Subscription Rights Price at 94.26 pence on 5 May 2026. The exercise date for the next Subscription Right is expected to be 30 April 2027.

The new Ordinary Shares subscribed for will be issued within 14 Business Days of the relevant Subscription Date to those Shareholders in whose name the Ordinary Shares are registered on the Subscription Date.

 

Enquiries

For further information, please contact:

Manulife | CQS Investment Management 

Craig Cleland

T: +44 (0) 20 7201 5368

Cavendish Capital Markets Limited

Tunga Chigovanyika

 (Corporate Finance)

T: +44 (0) 20 7397 1915



Daniel Balabanoff / Pauline Tribe (Sales)

T: +44 (0) 20 7220 0500

Summit Fund Services Jersey Limited

Christopher Foulds

T: +44 (0) 1534 825 259

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
UK 100

Latest directors dealings